| Jeein Kim, | |
|
34675 Yucaipa Blvd Ste 103, Yucaipa, CA 92399-4155 | |
| (909) 790-4537 | |
| Not Available |
| Full Name | Jeein Kim |
|---|---|
| Gender | Female |
| Speciality | Dentist - General Practice |
| Location | 34675 Yucaipa Blvd Ste 103, Yucaipa, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1497462295 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1223G0001X | Dentist - General Practice | 107818 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Jeein Kim, 26149 Park Ave Unit 56, Loma Linda, CA 92354-6128 Ph: (423) 331-9560 | Jeein Kim, 34675 Yucaipa Blvd Ste 103, Yucaipa, CA 92399-4155 Ph: (909) 790-4537 |
News Archive
In an ambitious effort to stem the dangerous tide of tuberculosis (TB) and deadly drug-resistant TB around the world, TB Alliance today announced that it has launched a first-of-its-kind clinical trial to test a novel drug combination – in both patients who have TB and those who have multidrug-resistant TB (MDR-TB).
The drug rimonabant was developed as a treatment for obesity and its myriad of serious health consequences. Despite having its desired effects on weight, which it decreased, and on levels of glucose and fats in the blood, rimonabant was never approved for use in the US because of serious neurological side effects including depression and anxiety. Now, a team of researchers, led by George Kunos, at the National Institutes of Health, Bethesda, and Alexandros Makriyannis, at Northeastern University, Boston, have developed a drug that has the same positive effects in mice on levels of glucose and fats in the blood as rimonabant but none of the neurological side effects.
Oncotarget recently published "Simvastatin is a potential candidate drug in ovarian clear cell carcinomas" which reported that based on previous studies, the authors assessed the anti-proliferative effect of simvastatin, a Rho GTPase interfering drug, in three OCCC cell lines: JHOC-5, OVMANA and TOV-21G, and one high-grade serous ovarian cancer cell line, Caov3. The authors used the Rho GTPase interfering drug CID-1067700 as a control.
In North America, 20 to 25 percent of women and 18 to 21 percent of men of reproductive age report daily psychological stress. Although previous research has suggested that stress can decrease the odds of conception, few studies have examined this association among couples from the general population.
› Verified 9 days ago
Dr. Neal Antonio Johnson, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 34366 Yucaipa Blvd Ste K, Yucaipa, CA 92399 Phone: 909-797-9247 Fax: 909-354-3767 | |
Steven Mark Wolfram, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 11834 Bryant St, Suite #104, Yucaipa, CA 92399 Phone: 909-797-1452 Fax: 909-790-0702 | |
Dr. Mauricio Dossantos, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 12033 4th St Ste 7, Yucaipa, CA 92399 Phone: 909-790-1951 Fax: 909-790-1561 | |
Dr. Richard Robert Ramos, D.D.S. Dentist Medicare: Medicare Enrolled Practice Location: 34636 County Line Rd Ste 19, Yucaipa, CA 92399 Phone: 909-795-2585 Fax: 909-795-0046 | |
Dr. Nathaniel Wen-wei Leng, D.D.S Dentist Medicare: Medicare Enrolled Practice Location: 34880 Yucaipa Blvd, Yucaipa, CA 92399 Phone: 909-797-1136 | |
Dr. Craig Jackson Wright, D.D.S. Dentist Medicare: Not Enrolled in Medicare Practice Location: 33490 Oak Glen Rd Ste F, Yucaipa, CA 92399 Phone: 909-790-9300 Fax: 909-797-2600 | |
Dr. Sudhakar R Chokka, DDS Dentist Medicare: Medicare Enrolled Practice Location: 34880 Yucaipa Blvd, Yucaipa, CA 92399 Phone: 909-797-1136 Fax: 909-797-9866 |